The FDA has approved bioLytical Laboratories’ Insti HIV self test. The company touts it as the fastest home-use HIV test available in the U.S., with results in 60 seconds or less.
BioLytical said the test provides a private, portable and highly accurate option for individuals to determine their HIV status without needing appointments or lab visits, according to an Oct. 14 news release.
The single-use test requires one drop of blood and is designed to reduce barriers to HIV screening, particularly for individuals who face stigma, cost or geographic obstacles in accessing care.
BioLytical said the new test supports national goals to reduce HIV infections by 90% by 2030.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
